ALGS vs LI · rev $3.6M vs P/E 24, rev $16.06B
Aligos Therapeutics Inc (ALGS) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
ALGS currently screens at market cap $44.1M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the ALGS and LI stock pages for the full models.
Not investment advice.